Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease

Neuroscience Letters

Volumn 280, Issue 3, 2000, Pages 215-219

  Crawford, Fiona ^a   Abdullah, Laila ^a   Schinka, John ^a   Suo, Zhiming ^a   Gold, Mike ^b   Duara, Ranjan ^c   Mullan, Mike ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Alzheimer's disease; Angiotensin converting enzyme; Apolipoprotein E; Gender; Genetic risk factors

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ALZHEIMER DISEASE; CASE-CONTROL STUDIES; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; CONFIDENCE INTERVALS; FEMALE; FLORIDA; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; SEX CHARACTERISTICS;

EID: 0033962798     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00791-6     Document Type: Article

References (21)

1. Amant C., Bauters C., Bodart J.C., Lablanche J.M., Grollier G., Danchin N., Hamon M., Richard F., Helbecque N., McFadden E.P., Amouyel P., Bertrand M.E. D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation. 96:(1):1997;56-60.
2. Amouyel P., Richard F., Cottel D., Amant C., Codron V., Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci. Lett. 217:(2/3):1996;203-205.
3. Breteler M.M.B., de Groot J.C., de Leeuw F.E., Oudkerk M., Jolles J., van Gijn J., Hofman A. Determinants and consequences of cerebral white matter lesions. The Rotterdam Scan Study. Alzheimers Reports (from the oral presentation at the Vascular Factors in Alzheimer's Disease meeting, Newcastle, UK). 2:(1):1999;72.
4. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.P., Arveiler D., Luc G., Bard J.M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:(6396):1992;641-644.
5. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., Duijn C.M. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278:(16):1997;1349-1356.
6. Fogarty D., Maxwell A., Doherty C., Hughes A., Nevin N. ACE gene typing. Lancet. 343:1994;851.
7. Galinsky D., Tysoe C., Brayne C.E., Easton D.F., Huppert F.A., Dening T.R., Paykel E.S., Rubinsztein D.C. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 129:(2):1997;177-183.
8. Ge J., Barnes N. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders. Eur. J. Pharmacol. 297:(3):1996;299-306.
9. Kehoe P., Russ C., McIlory S., Williams H., Holmans P., Holmes C., Liolitsa D., Vahidassr D., Powell J., McGleenon B., Liddell M., Plomin R., Dynan K., Williams N., Neal J., Cairns N.J., Wilcock G., Passmore P., Lovestone S., Williams J., Owen M. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet. 21:(1):1999;71-72.
10. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott A., Amaducci L.A., Brayne C., Copeland J.R., Dartigues J.F., Kragh-Sorensen P., Lobo A., Martinez-Lage J.M., Stijnen T., Hofman A. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 52:(1):1999;78-84.
11. Mii S., Ware J.A., Mallette S.A., Kent K.C. Effect of angiotensin II on human vascular smooth muscle cell growth. J. Surg. Res. 57:(1):1994;174-178.
12. Mullan M., Scibelli P., Duara R., Fallin D., Gold M., Schinka J., Hoyne J., Osborne A., Sevush S., Crawford F. Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann. N.Y. Acad. Sci. 802:1996;16-26.
13. Palumbo B., Cadini D., Nocentini G., Filipponi E., Fravolini M.L., Senin U. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci. Lett. 267:(2):1999;97-100.
14. Pueyo M.E., N'Diaye N., Michel J.B. Angiotensin II-elicited signal trans-duction via AT1 receptors in endothelial cells. Br. J. Pharmacol. 118:(1):1996;79-84.
15. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:(4):1990;1343-1346.
16. Rigat B., Hubert C., Corvol P., Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 20:(6):1992;1433.
17. Sagnella G.A., Rothwell M.J., Onipinla A.K., Wicks P.D., Cook D.G., Cappuccio F.P. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J. Hypertens. 17:(5):1999;657-664.
18. Schachter F., Faure-Delanef L., Guenot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet. 6:(1):1994;29-32.
19. Singer D.R., Missouris C.G., Jeffery S. Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion. Circulation. 94:(3):1996;236-239.
20. Skoog I. Cardiovascular and related vascular risk factors for Alzheimer's disease. Alzheimers reports special issue (from the oral presentation at the Vascular Factors in Alzheimer's Disease meeting, Newcastle, UK). 2:(1):1999;62.
21. Tsuang D., Kukull W., Sheppard L., Barnhart R.L., Peskind E., Edland S.D., Schellenberg G., Raskind M., Larson E.B. Impact of sample selection on APOE ε4 allele frequency: a comparison of two Alzheimer's disease samples. J. Am. Geriatr. Soc. 44:(6):1996;704-707.